Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Fluoroscopy-Guided vs. Ultrasound-Guided Transfemoral Access in Complex PCI: Results of the ULTRACOLOR Study

During complex percutaneous coronary interventions (PCI), it is common to use large-caliber guidewire catheters to provide greater support. Large-caliber transradial access has proven to be viable and safe in such procedures. However, a small radial artery, severe spasm, or variant anatomy are contraindications for this access, making transfemoral access a better choice in these cases.

¿Deberíamos adoptar el uso rutinario del ultrasonido para guiar el acceso femoral?

The use of ultrasound-guided puncture for transfemoral access has been shown to reduce vascular complications, but its use is not a routine procedure. In the recent UNIVERSAL clinical trial, ultrasound-guided transfemoral puncture did not result in a significant reduction in bleeding or vascular complications compared to fluoroscopy-guided access.

 It is worth noting that one of the limitations of this trial was the low proportion of complex PCI cases and that most of the accesses used were 6 Fr. It is currently unclear whether there is any benefit in using ultrasound to guide transfemoral access in the case of large-caliber catheters (>7 Fr).

The objective of this multicenter randomized study was to demonstrate the superiority of ultrasound over fluoroscopy in complex PCI, specifically in terms of bleeding and/or vascular complications (BARC 2, 3, 5) that require intervention during hospitalization.

Lea también: Tratamiento borde a borde en la válvula tricuspídea: evolución a un año.

The primary endpoint (PE) was defined as clinically relevant bleeding at the access site or a vascular complication that required intervention during hospitalization. The secondary endpoint (SE) covered safety and efficacy aspects, including BARC 2, 3, or 5 bleeding at the transfemoral access site at 30 days of follow-up, BARC 2, 3, or 5 bleeding at secondary femoral or radial artery sites, major adverse cardiovascular events (MACE) at 30 days, vascular complications that did not require intervention, procedure time, access time, and success rate at the first puncture.

The study included a total of 544 patients, of whom 274 were randomized to the ultrasound-guided group and 270 to the fluoroscopy-guided group. The mean age was 71 years, and 76% of the subjects were men. The most frequent indication for complex PCI was stable angina, and 68% of patients required PCI for chronic total occlusion. The PE occurred in 18.9% of the fluoroscopy-guided group, compared with 15.7% of the ultrasound-guided group (p=0.32). 

The success rate for the first puncture was 92% for the ultrasound-guided group, compared with 85% for the fluoroscopy-guided group (p=0.02). The median catheterization lab time was 102 minutes for the ultrasound group and 105 minutes for the fluoroscopy group (p=0.43), while the MACE rate at one month was 4.1% for the fluoroscopy group and 2.6% for the ultrasound-guided access group (p=0.32).

Conclusión 

Routine use of ultrasound to guide transfemoral puncture in complex PCI did not significantly reduce clinically relevant bleeding or vascular complications compared with fluoroscopy, although it did improve first puncture success.

Original Title: Ultrasound-guided versus fluoroscopy-guided large-bore femoral access in PCI of complex coronary lesions: the international, multicentre, randomised ULTRACOLOR Trial.

Reference: Thomas A. Meijers , MD et al EuroIntervention 2024;20:e876-e886.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Andrés Rodríguez
Dr. Andrés Rodríguez
Member of the Editorial Board of solaci.org

Más artículos de este Autor

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Artículos relacionados

Jornadas Guatemala 2026
Jornadas SOLACIspot_img

Artículos recientes

Registration Open for Module 2 of the 2026 Annual Course: Multislice CT and Cardiovascular Magnetic Resonance Imaging

The Latin American Society of Interventional Cardiology (SOLACI) and the Argentine College of Interventional Cardioangiologists (CACI) announce the opening of registration for Module 2...

Open Session | Current Endovascular Treatment of Tricuspid Regurgitation

SOLACI and the Argentine College of Interventional Cardioangiologists (CACI) invite you to participate in a new Open Session of the Advanced Postgraduate Course in...

DOUBLE-CHOICE: Lower Pacemaker Implantation Rates with ACURATE neo2 Compared with Evolut in Patients Undergoing TAVI

The DOUBLE-CHOICE trial is a multicenter, randomized, controlled study conducted in Germany to evaluate the performance of next-generation transcatheter heart valves and different anesthesia...